l, Inc. (OXIS) is the premiere provider for the potent antioxidant, Ergothioneine and through
their patented synthetic manufacturing process remains the only significant commercial source of pure l-ergothioneine worldwide .
The products of the company include therapeutic nutraceutical products, cosmeceutical products and proprietary formulations and clinical products that are developed internally and/or out-licensed to biotech and pharmaceutical companies as drug candidates. The company is focused on naturally occurring protective substances since they are more likely to be both safe and efficacious.
The primary products of Oxis incorporate and emphasize the multifaceted “super antioxidant” compound, L- Ergothioneine (“ERGO”) , GLUTATHIONE PEROXIDASE (GPX) as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process. It produces the compounds which TREAts OXIDATIVE STRESS by controlling free radicles and hence it is very helpful as an anti aging compound as well.
Oxis is listed under the category of penny stocks which can be a great opportunity for inverstors.Investers can contact us through our website for more information.
For more info visit: http://www.oxis.com
Hack Facebook online psp,xbox games Hack Facebook Online
No comments:
Post a Comment